Ascendis Pharma A/S (ASND)

NASDAQ

$251.76

Ascendis Pharma A / S, a biopharmaceutical company, develops therapies for unmet medical needs. The company is headquartered in Hellerup, Denmark.

Sector:

Industry:

68 analysts

Strong Buy

Target: $301.55 (+19.78%)

Market Cap

$17B

Revenue 5Y CAGR

+175.66%

Profit Margin

57.3%

Forward P/E

16.39

Adjust inflation

Log

Valuation

Market Cap$17B

P/E30.09

Forward P/E16.39

P/S20.12

P/B31.35

Profitability

Total Revenue (TTM)$1B

Gross Profit (TTM)$891M

EBITDA$14M

Profit Margin57.3%

Operating Margin10.1%

EPS$8.93

Financial Health

Debt-to-Equity183.8%

Free Cash Flow Yield0.29%

Growth & Risk

Revenue 5Y CAGR+175.66%

Beta (5Y)0.44

Sharpe Ratio1.04